Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.
- DOI
- 10.2147/ott.s635500
- Published
- 2026
- Container
- OncoTargets and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ott.s635500,
title = {Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.},
author = {Chen S and Wu S and Zhang J and Qiang X and Liu S and Yang W and Peng X and Zhang X and Ren J and Zhang C},
year = {2026},
journal = {OncoTargets and therapy},
doi = {10.2147/ott.s635500},
url = {https://doi.org/10.2147/ott.s635500}
}RIS
TY - JOUR TI - Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia. AU - Chen S AU - Wu S AU - Zhang J AU - Qiang X AU - Liu S AU - Yang W AU - Peng X AU - Zhang X AU - Ren J AU - Zhang C PY - 2026 JO - OncoTargets and therapy DO - 10.2147/ott.s635500 UR - https://doi.org/10.2147/ott.s635500 ER -
APA
S, C., S, W., J, Z., X, Q., S, L., W, Y., X, P., X, Z., J, R., & C, Z. (2026). Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia.. OncoTargets and therapy. https://doi.org/10.2147/ott.s635500
Source records
- pubmed · retrieved 2026-09-25T04:43:50.558Z